Two pronged approach for prevention and therapy of COVID-19 (Sars-CoV-2) by a multi-targeted herbal drug, a component of ayurvedic decoction
Authors:
- 1 April 2021
- journal article
- research article
- Published by Elsevier in European Journal of Integrative Medicine
- Vol. 43, 101268
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Human Resource Development
This publication has 17 references indexed in Scilit:
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- On the origin and continuing evolution of SARS-CoV-2National Science Review, 2020
- The SARS-CoV-2 Vaccine Pipeline: an OverviewCurrent Tropical Medicine Reports, 2020
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challengesInternational Journal of Antimicrobial Agents, 2020
- The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?International Journal of Epidemiology, 2020
- Identification of Inhibitors against Metastasis Protein “Survivin:” In silico Discovery Using Virtual Screening and Molecular Docking Studies2018
- Phytochemical and bioactive compounds identification of Ocimum tenuiflorum leaves of methanol extract and its fraction with an anti-diabetic potentialInternational Journal of Food Properties, 2018
- Predicting Binding Affinities for GPCR Ligands Using Free-Energy PerturbationACS Omega, 2016
- Ginger and Its Constituents: Role in Prevention and Treatment of Gastrointestinal CancerGastroenterology Research and Practice, 2015
- Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking AccuracyJournal of Medicinal Chemistry, 2004